Composition
- Active ingredients
- NECITUMUMAB 800MG/50ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA125547.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Portrazza
- Active substance
- necitumumab
- Route
- Into a joint, Intramuscular, Intravitreal
- Dosage form
- Injectable
- Applicant
- Eli Lilly Co
- Status
- Prescription
- FDA approval
- 24 Nov 2015
- Application
- BLA125547-001